Geron reported $-30098000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 1476M 423M
Bio Techne TECH:US $ 60.74M 19.43M
Cti Biopharma CTIC:US $ -37.17M 0.39M
Cytokinetics CYTK:US $ -89.44M 58.88M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Exelixis EXEL:US $ 68.57M 26.59M
Genmab GEN:DC DK 465M 251M
Geron GERN:US $ -30.1M 1.92M
Gilead Sciences GILD:US $ 19M 363M
Macrogenics MGNX:US $ -66.44M 8.42M
Novartis NOVN:VX SF 2222M 14086M
Novavax NVAX:US $ 203.41M 1049.69M
Pain Therapeutics PTIE:US $ -17.53M 3.36M
Seattle Genetics SGEN:US $ -136.49M 38.13M
YTE INCY:US $ 37.99M 525.86M